Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (3)

2024

  1. Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study

    Pain and Therapy, Vol. 13, Núm. 3, pp. 557-576

2023

  1. Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine

    Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334

2022

  1. Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain

    Patient Preference and Adherence, Vol. 16, pp. 3291-3302